tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market

Travere Therapeutics (TVTX) Income Statement

Compare
464 Followers

Travere Therapeutics Income Statement

Last quarter (Q4 2024), Travere Therapeutics's total revenue was $74.79M, an increase of 65.98% from the same quarter last year. In Q4, Travere Therapeutics's net income was $-60.26M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 233.18M$ 145.24M$ 212.02M$ 227.49M$ 198.32M
Gross Profit
$ 233.18M$ 133.79M$ 204.43M$ 220.71M$ 192.19M
Operating Expenses
$ 557.00M$ 521.93M$ 455.99M$ 360.21M$ 267.57M
Depreciation and Amortization
$ 43.55M$ 38.53M$ 20.72M$ 26.62M$ 25.79M
EBITDA
$ -265.77M$ -326.25M$ -299.42M$ -186.68M$ -143.95M
Operating Income
$ -320.63M$ -376.74M$ -251.56M$ -139.50M$ -75.38M
Other Income/Expenses
$ 120.00K$ 634.00K$ -11.34M$ 19.74M$ -113.41M
Pretax Income
$ -320.51M$ -376.11M$ -278.17M$ -179.68M$ -188.79M
Net Income
$ -321.55M$ -111.40M$ -278.48M$ -180.09M$ -169.43M
Per Share Metrics
Basic EPS
$ -4.08$ -1.50$ -4.37$ -3.01$ -3.56
Diluted EPS
$ -4.08$ -1.50$ -4.37$ -3.01$ -3.56
Weighted Average Shares Outstanding
78.89M 74.27M 63.76M 59.83M 47.54M
Weighted Average Shares Outstanding (Diluted)
78.89M 74.27M 63.76M 59.83M 47.54M
Currency in USD

Travere Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis